Saturday, 19 September 2020

Immunotherapy Drug Avelumab Improves Survival in Advanced Bladder Cancer Patients

An immune drug avelumab has resulted in a survival advantage in bladder cancer, and will potentially benefit thousands of patients each year, said new study.


from Medindia Health News https://ift.tt/2EeiVVV

No comments:

Post a Comment